Zhejiang Jiuzhou Pharm Co Ltd - Asset Resilience Ratio

Latest as of June 2022: 0.01%

Zhejiang Jiuzhou Pharm Co Ltd (603456) has an Asset Resilience Ratio of 0.01% as of June 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Zhejiang Jiuzhou Pharm Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.06 Million
≈ $155.05K USD Cash + Short-term Investments

Total Assets

CN¥7.93 Billion
≈ $1.16 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2010–2021)

This chart shows how Zhejiang Jiuzhou Pharm Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Zhejiang Jiuzhou Pharm Co Ltd's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Jiuzhou Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Zhejiang Jiuzhou Pharm Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.06 Million 0.01%
Total Liquid Assets CN¥1.06 Million 0.01%

Asset Resilience Insights

  • Limited Liquidity: Zhejiang Jiuzhou Pharm Co Ltd maintains only 0.01% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Zhejiang Jiuzhou Pharm Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Jiuzhou Pharm Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM
Drug Manufacturers - Specialty & Generic 2.79%
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Beijing Tongrentang Co Ltd
SHG:600085
Drug Manufacturers - Specialty & Generic 2.51%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
Drug Manufacturers - Specialty & Generic 20.44%
Harbin Pharmaceutical Group Co Ltd
SHG:600664
Drug Manufacturers - Specialty & Generic 0.97%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%

Annual Asset Resilience Ratio for Zhejiang Jiuzhou Pharm Co Ltd (2010–2021)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Jiuzhou Pharm Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2021-12-31 0.37% CN¥26.06 Million
≈ $3.81 Million
CN¥7.04 Billion
≈ $1.03 Billion
-0.18pp
2020-12-31 0.55% CN¥27.45 Million
≈ $4.02 Million
CN¥5.00 Billion
≈ $731.92 Million
-0.36pp
2018-12-31 0.91% CN¥30.00 Million
≈ $4.39 Million
CN¥3.30 Billion
≈ $483.61 Million
-12.43pp
2015-12-31 13.34% CN¥445.00 Million
≈ $65.12 Million
CN¥3.34 Billion
≈ $488.05 Million
+8.81pp
2014-12-31 4.53% CN¥100.00 Million
≈ $14.63 Million
CN¥2.21 Billion
≈ $323.13 Million
+3.58pp
2013-12-31 0.95% CN¥14.66 Million
≈ $2.15 Million
CN¥1.55 Billion
≈ $226.96 Million
+0.65pp
2012-12-31 0.29% CN¥3.94 Million
≈ $577.26K
CN¥1.34 Billion
≈ $196.57 Million
+0.08pp
2010-12-31 0.21% CN¥1.81 Million
≈ $264.45K
CN¥855.97 Million
≈ $125.25 Million
--
pp = percentage points

About Zhejiang Jiuzhou Pharm Co Ltd

SHG:603456 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.09 Billion
CN¥14.28 Billion CNY
Market Cap Rank
#6063 Global
#1168 in China
Share Price
CN¥16.20
Change (1 day)
+0.00%
52-Week Range
CN¥12.18 - CN¥21.87
All Time High
CN¥60.21
About

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecules, drug products, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, an… Read more